Carregant...
TLR Agonists as Vaccine Adjuvants Targeting Cancer and Infectious Diseases
Modern vaccines have largely shifted from using whole, killed or attenuated pathogens to being based on subunit components. Since this diminishes immunogenicity, vaccine adjuvants that enhance the immune response to purified antigens are critically needed. Further advantages of adjuvants include dos...
Guardat en:
| Publicat a: | Pharmaceutics |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
MDPI
2021
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7911620/ https://ncbi.nlm.nih.gov/pubmed/33499143 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/pharmaceutics13020142 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|